1,730 Shares in Chemed Co. (NYSE:CHE) Purchased by Parr Mcknight Wealth Management Group LLC

Parr Mcknight Wealth Management Group LLC acquired a new stake in Chemed Co. (NYSE:CHE - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,730 shares of the company's stock, valued at approximately $917,000.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. CIBC Asset Management Inc grew its stake in shares of Chemed by 5.1% in the 4th quarter. CIBC Asset Management Inc now owns 457 shares of the company's stock valued at $242,000 after buying an additional 22 shares during the period. CBIZ Investment Advisory Services LLC lifted its position in shares of Chemed by 64.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock worth $30,000 after buying an additional 22 shares in the last quarter. CIBC Private Wealth Group LLC raised its holdings in shares of Chemed by 13.5% in the 4th quarter. CIBC Private Wealth Group LLC now owns 185 shares of the company's stock worth $98,000 after purchasing an additional 22 shares during the period. Independent Advisor Alliance raised its holdings in shares of Chemed by 1.1% in the 4th quarter. Independent Advisor Alliance now owns 2,279 shares of the company's stock worth $1,207,000 after purchasing an additional 25 shares during the period. Finally, EverSource Wealth Advisors LLC grew its stake in Chemed by 7.1% in the 4th quarter. EverSource Wealth Advisors LLC now owns 498 shares of the company's stock valued at $264,000 after buying an additional 33 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 1,000 shares of Chemed stock in a transaction on Monday, March 31st. The shares were sold at an average price of $615.33, for a total value of $615,330.00. Following the completion of the transaction, the chief executive officer now directly owns 101,679 shares of the company's stock, valued at $62,566,139.07. This trade represents a 0.97% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, EVP Spencer S. Lee sold 1,500 shares of Chemed stock in a transaction on Friday, May 16th. The stock was sold at an average price of $577.99, for a total transaction of $866,985.00. Following the completion of the transaction, the executive vice president now directly owns 14,627 shares of the company's stock, valued at $8,454,259.73. The trade was a 9.30% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 7,500 shares of company stock worth $4,401,120. Company insiders own 3.29% of the company's stock.

Chemed Stock Performance

Shares of NYSE:CHE traded up $9.96 during trading on Tuesday, reaching $579.53. 175,138 shares of the stock traded hands, compared to its average volume of 103,353. The stock has a 50-day moving average of $582.91 and a two-hundred day moving average of $565.59. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $623.61. The stock has a market cap of $8.48 billion, a P/E ratio of 29.28, a price-to-earnings-growth ratio of 2.15 and a beta of 0.59.

Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, beating analysts' consensus estimates of $5.59 by $0.04. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The firm had revenue of $646.94 million for the quarter, compared to analysts' expectations of $641.78 million. During the same quarter in the prior year, the company posted $5.20 earnings per share. The business's revenue for the quarter was up 9.8% on a year-over-year basis. Sell-side analysts expect that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 17th. Investors of record on Thursday, May 29th will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.35%. The ex-dividend date is Thursday, May 29th. Chemed's dividend payout ratio is currently 9.74%.

Analyst Upgrades and Downgrades

CHE has been the subject of a number of recent analyst reports. Wall Street Zen upgraded shares of Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th. Royal Bank of Canada upped their price objective on shares of Chemed from $667.00 to $674.00 and gave the company an "outperform" rating in a research note on Monday, April 28th.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.